(1)
Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido Thiazolyl Resorcinol) in Melasma. J of Skin 2025, 9 (2), s544. https://doi.org/10.25251/skin.10.supp.544.